Published on: 29 October 2020 Roche’s Tecentriq in combination with Avastin approved in China for people with the most common form of liver cancer more
Published on: 22 October 2020 Roche announces collaboration with Atea Pharmaceuticals to develop a potential oral treatment for COVID-19 patients more
